Joining EMBL as a technology developer and engineer
Integrated structure and metabolomics platform for microbial targets
Supported by the ARISE program, deadline: November 30, 2021
The Wilmanns Group at the EMBL Hamburg Unit aims to establish a
multidisciplinary metabolomics/structure service platform for
determination of turnover mechanisms of specific drugs or prodrugs by
different microorganisms, in collaboration with Michael Zimmermann,
Structural & Computational Biology Unit, EMBL Heidelberg. The platform
will include establishment of a pipeline for high resolution structures
of selected protein-drug complexes in microorganisms, and in-vitro
analysis of the enzymatic processing of specific drugs by microorganisms.
In case of further interest please contact:
Matthias Wilmanns, email: matthias.wilmanns@embl-hamburg.de
Michael Zimmermann, email: michael.zimmermann@embl.de
For more information on the position, please visit:
https://www.embl.org/jobs/position/EF00004